Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients

Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients

Objectives: Identifying simple biomarkers to determine muscle atrophy in non-small-cell lung cancer (NSCLC) patients remains a critical research gap. Since creatinine is mainly a product from intramuscular creatine metabolism, we tested the hypothesis that low serum creatinine levels would be associ...

Full description

Bibliographic Details
Main Authors: Willian das Neves, Christiano R. R. Alves, Ana Paula de Souza Borges, Gilberto de Castro
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Physiology
Subjects:
cancer cachexia
muscle atrophy
creatinine metabolism
muscle wasting
sarcopenia
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.625417/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2021.625417/full

Similar Items